The manufacturing of cancer drugs must comply with Good Manufacturing Practice (GMP) guidelines to ensure the consistent quality of products. GMP guidelines cover various aspects, including facility standards, equipment maintenance, and quality control procedures. Regulatory inspections are conducted to verify compliance with these standards.